Thiopurine Methyltransferase Predicts the Extent of Cytotoxicty and DNA Damage in Astroglial Cells after Thioguanine Exposure

6-Thioguanine andS6-Methylthioguanine Are Mutagenic in Human Cells

(2010) Bifeng Yuan et al.   ACS Chemical Biology

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

(2010) M. A. Smith et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A miR-21 hairpin structure-based gene knockdown vector

(2010) Junming Yue et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Azathioprine-Induced Carcinogenesis in Mice According to Msh2 Genotype

(2010) Alexandra Chalastanis et al.   JNCI-Journal of the National Cancer Institute

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Munster protocols

(2009) M. Stanulla et al.   BLOOD

Coordination of DNA Mismatch Repair and Base Excision Repair Processing of Chemotherapy and Radiation Damage for Targeting Resistant Cancers

(2009) T. J. Kinsella   CLINICAL CANCER RESEARCH

Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine

(2009) Emmanuella Guenova et al.   MELANOMA RESEARCH

The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells

(2009) N. Cooley et al.   TOXICOLOGY

Mutagenic and Cytotoxic Properties of 6-Thioguanine,S6-Methylthioguanine, and Guanine-S6-sulfonic Acid

(2008) Bifeng Yuan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY